⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL931042 | 1.00 | — | — | |
| SCHEMBL167570 | 1.00 | — | — | |
| Ether SCHEMBL4505129 | 0.87 | CYP1A2 (0.49) | — | |
| SCHEMBL5155772 | 0.86 | — | — | |
| SCHEMBL5156795 | 0.86 | — | — | |
| SCHEMBL863827 | 0.86 | — | — | |
| SCHEMBL22166739 | 0.85 | CYP1A2 (0.38) | — | |
| SCHEMBL18227564 | 0.82 | — | — | |
| SCHEMBL863604 | 0.82 | — | — | |
| SCHEMBL864461 | 0.79 | CYP1A2 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106667897-A | Biodegradable slow/controlled-release drug delivery system and preparation method thereof | 辽宁省计划生育科学研究院 | 2017-05-17 | — | — | CN | claimed |
| CN-102911350-B | Application of hexahydric cyclic carbonate in biodegradable materials | LIAONING RES INST OF FAMILY PLANNING | 2014-06-25 | — | — | CN | claimed |
| CN-102911350-A | Application of hexahydric cyclic carbonate in biodegradable materials | LIAONING RES INST OF FAMILY PLANNING | 2013-02-06 | — | — | CN | claimed |
| CN-1064484-A | New tetrahydrofuran (THF) intermediate | BRISTOL MYERS SQUIBB CO (US) | 1992-09-16 | — | — | CN | claimed |
| EP-0502447-A1 | Tetrahydrofuran intermediates | Bristol-Myers Squibb Company (US) | 1992-09-09 | — | — | EP | claimed |
| JP-57118578-A | — | — | None | — | — | JP | disclosed |
| JP-5105695-A | — | — | None | — | — | JP | disclosed |
| US-20250122223-A1 | HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS | ALMAC DISCOVERY LIMITED (GB) | 2025-04-17 | — | — | US | disclosed |
| CN-113677423-B | Graft copolymer film and nanoporous polypropylene film having polypropylene backbone | SABIC环球技术有限责任公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-115490708-B | Sulfonamide macrocyclic derivative, preparation method and application thereof | 苏州亚盛药业有限公司 | 2025-01-24 | — | — | CN | disclosed |
| EP-4466072-A1 | HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS | Almac Discovery Limited (GB) | 2024-11-27 | — | — | EP | disclosed |
| CN-118946566-A | Heterocyclic compounds as ubiquitin-specific protease 7 inhibitors | 阿尔麦克探索有限公司 | 2024-11-12 | — | — | CN | disclosed |
| JP-H05105695-A | TETRAHYDROFURAN INTERMEDIATE | BRISTOL MYERS SQUIBB CO | 1993-04-27 | — | — | JP | disclosed |
| CN-1064681-A | The method for preparing nucleoside derivates | BRISTOL MYERS SQUIBB CO (US) | 1992-09-23 | — | — | CN | disclosed |
| CN-1064484-A | New tetrahydrofuran (THF) intermediate | BRISTOL MYERS SQUIBB CO (US) | 1992-09-16 | — | — | CN | disclosed |
| EP-0502447-A1 | Tetrahydrofuran intermediates | Bristol-Myers Squibb Company (US) | 1992-09-09 | — | — | EP | disclosed |
| EP-0501511-A2 | Processes for preparation of nucleoside derivatives | Bristol-Myers Squibb Company (US) | 1992-09-02 | — | — | EP | disclosed |
| EP-0357571-A2 | Pyrimidine nucleosides | Medivir Aktiebolag (SE) | 1990-03-07 | — | — | EP | disclosed |
| WO-1989012061-A1 | PYRIMIDINE NUCLEOSIDES AND INTERMEDIATES | MEDIVIR AB (SE) | 1989-12-14 | — | — | WO | disclosed |
| JP-S57118578-A | PREPARATION OF (R)-(-)-5-TRITYLOXYMETHYLTETRAHYDROFURAN- 2-ONE | KAWAKEN FINE CHEM CO LTD | 1982-07-23 | — | — | JP | disclosed |